Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial (Q39316867)

11 September 2017

title

Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial (English)

1 reference

11 September 2017

18

1 reference

11 September 2017

13

Ifeoma I Ulasi

1 reference

11 September 2017

4

Samuel Kingue

1 reference

11 September 2017

3

Lutgarde Thijs

1 reference

11 September 2017

14

Benedict C Anisiuba

1 reference

11 September 2017

15

Chinwuba K Ijoma

1 reference

11 September 2017

Augustine N Odili

1

1 reference

11 September 2017

Tom Richart

2

1 reference

11 September 2017

Hilaire J Boombhi

5

1 reference

11 September 2017

Daniel Lemogoum

6

1 reference

11 September 2017

Joseph Kaptue

7

1 reference

11 September 2017

Marius K Kamdem

8

1 reference

11 September 2017

Jean-Bruno Mipinda

9

1 reference

11 September 2017

Babatunde A Omotoso

10

1 reference

11 September 2017

Philip M Kolo

11

1 reference

11 September 2017

Ademola Aderibigbe

12

1 reference

11 September 2017

Serigne A Ba

16

1 reference

11 September 2017

Mouhamadou B Ndiaye

17

1 reference

11 September 2017

Jean-René M'buyamba-Kabangu

19

1 reference

11 September 2017

NOAAH Investigators

20

1 reference

11 September 2017

publication date

15 April 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

20

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

256-266

1 reference

Mortality by cause for eight regions of the world: Global Burden of Disease Study

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Emerging epidemic of cardiovascular disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

The burden of blood pressure-related disease: a neglected priority for global health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Hypertension in sub-Saharan African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Admixture mapping for hypertension loci with genome-scan markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Determinants of hypertension in West Africa: contribution of anthropometric and dietary factors to urban-rural and socioeconomic gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Reference values for SphygmoCor measurements in South Africans of African ancestry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Disease burden in sub-Saharan Africa: what should we conclude in the absence of data?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Causes of admissions of rural African patients to Murchison Hospital, Natal, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Heart failure in sub-saharan Africa: time for action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Stroke in young Nigerian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Epidemiology of stroke and high blood pressure in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

An epidemiological study of stroke hospitalizations in Maputo, Mozambique: a high burden of disease in a resource-poor country

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Sexual dysfunction among Ghanaian men presenting with various medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

End-stage renal disease in sub-Saharan and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

[A new look at adult chronic heart failure in Africa in the age of the Doppler echocardiography: experience of the medicine department at Yaounde General Hospital]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Pattern of aortic aneurysms in an African country.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Better blood pressure control: how to combine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Hypertension and ethnic group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Management of hypertension in ethnic minorities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Amlodipine and valsartan as components of a rational and effective fixed-dose combination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Conduct of clinical trials in developing countries: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Host and environmental determinants of heart rate and heart rate variability in four European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Antihypertensive Treatment Based on Blood Pressure Measurement at Home or in the Physician's Office A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2011.572614

10.3109/08037051.2011.572614

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference